You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 17, 2026

Drug Price Trends for ALUMINUM HYDROXIDE GEL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ALUMINUM HYDROXIDE GEL

Average Pharmacy Cost for ALUMINUM HYDROXIDE GEL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ALUMINUM HYDROXIDE GEL 00536-0091-85 0.01253 ML 2026-03-18
ALUMINUM HYDROXIDE GEL 00536-0091-85 0.01257 ML 2026-02-18
ALUMINUM HYDROXIDE GEL 00536-0091-85 0.01284 ML 2026-01-21
ALUMINUM HYDROXIDE GEL 00536-0091-85 0.01311 ML 2025-12-17
ALUMINUM HYDROXIDE GEL 00536-0091-85 0.01329 ML 2025-11-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

ALUMINUM HYDROXIDE GEL Market Analysis and Financial Projection

Last updated: February 14, 2026

Market Overview and Price Projections for Aluminum Hydroxide Gel

Current Market Size and Usage

Aluminum Hydroxide Gel is a topical antacid used for treating hyperacidity, duodenal ulcers, and gastric conditions. It is also incorporated into antacid formulations sold over-the-counter (OTC). The global market for antacids, including aluminum hydroxide gel, has grown steadily, driven by increasing prevalence of gastrointestinal disorders and OTC product demand.

Market Size (2022): Estimated $1.2 billion worldwide for aluminum hydroxide-based antacids, with a compound annual growth rate (CAGR) of approximately 4.3% from 2017 to 2022 [1].

Key Markets: North America (over 35%), Europe (around 20%), Asia-Pacific (roughly 25%), Latin America and Middle East share that continue to expand with rising health awareness and urbanization.

Competitive Landscape

Major manufacturers include:

  • GlaxoSmithKline (Gaviscon)
  • Bayer (Aludrox)
  • Glenmark
  • Sun Pharmaceutical
  • Mylan

Most products use aluminum hydroxide gel as the primary active ingredient, often combined with magnesium hydroxide to balance constipating effects.

Regulatory Environment

  • United States: OTC status regulated by the FDA under monograph system; aluminum hydroxide gel classified as GRASE (Generally Recognized As Safe).
  • Europe: Registered as medicinal product; EMA regulations apply.
  • Asia-Pacific: Regulatory pathways vary; more flexible in countries like India.

Manufacturing Dynamics and Cost Factors

Raw material cost (aluminum hydroxide raw material) fluctuates with aluminum prices, which have ranged from $2,000 to $2,500 per ton historically [2]. Manufacturing costs include synthesis, quality control, and packaging, typically accounting for approximately 30-50% of the wholesale price.

Price Trends and Projections

Current Wholesale Price Range (2023): $0.50–$1.50 per gram, depending on formulation, packaging, and regional markup.

Pricing Factors:

  • Raw material costs
  • Regulatory compliance costs
  • Market competition
  • Distribution channels

Forecast (2024-2028): Prices are projected to experience a slight decline, averaging 2-3% annually. This decline results from increased generic competition and manufacturing efficiencies.

Year Estimated Price per Gram Notes
2023 $0.50 – $1.50 Range varies by region and producer
2024 $0.49 – $1.46 Slight decrease due to competition
2025 $0.48 – $1.43 Market expansion adding new entrants
2026 $0.47 – $1.40 Raw material cost stability maintains price trend
2027 $0.46 – $1.37 Price compression continues
2028 $0.45 – $1.34 Further erosion expected in price margins

Future Market Drivers

  • Rise in gastrointestinal disorders due to lifestyle changes.
  • Growth of OTC antacid markets in emerging economies.
  • Increased focus on combination therapies with magnesium hydroxide and others.
  • Patent expirations enabling generic manufacturing.

Potential Risks

  • Regulatory changes increasing compliance costs.
  • Raw material price volatility influencing manufacturing costs.
  • Market saturation in mature regions.

Key Takeaways

  • The global aluminum hydroxide gel market is valued at approximately $1.2 billion, growing modestly.
  • Price per gram is currently $0.50–$1.50, forecasted to decline slightly over the next five years.
  • Market growth driven by rising gastrointestinal illness prevalence and OTC demand.
  • Price pressure from generic manufacturers will sustain over the forecast period.

FAQs

1. What factors influence the raw material costs of aluminum hydroxide gel?
Aluminum prices, energy costs, and refining efficiencies impact raw material costs.

2. How does regulatory status differ across major markets?
In the US, aluminum hydroxide gel is OTC-approved and classified as GRASE. In Europe, it requires registration as a medicinal product. Asian regulatory pathways vary but tend to be less restrictive in developing countries.

3. What is the outlook for new formulations combining aluminum hydroxide gel with other antacids?
Such combinations are common and expected to increase, driven by patient preference for multi-action formulations.

4. How does market competition impact pricing?
Increased generic competition exerts downward pressure on prices, especially beyond patent expirations, maintaining a slow decline trend.

5. What are the potential growth regions for aluminum hydroxide gel?
Emerging markets in Asia-Pacific and Latin America are poised for expansion due to increasing healthcare infrastructure and awareness.


Citations

[1] MarketWatch, "Global Antacid Market Size, Share & Trends," 2022.
[2] London Metal Exchange, "Aluminum Price History," 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.